Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary

No abstract is available for this paper.

• Publication year

  2017

• Venue

  European Respiratory Journal

• Publication date

  2017-01-30

• Fields of study

  Medicine

• Identifiers
  DOI 10.1183/13993003.00214-2017PMID 28182564
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Combined pharmacotherapy and behavioural interventions for smoking cessation

  2019cited by this paper
• Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices

  2019cited by this paper
• Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease.

  2019cited by this paper
• Chronic obstructive pulmonary disease in over 16s: diagnosis and management

  2018cited by this paper
• Peripheral Artery Disease and Its Clinical Relevance in Patients with Chronic Obstructive Pulmonary Disease in the COPD and Systemic Consequences‐Comorbidities Network Study

  2017cited by this paper
• Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease.

  2017cited by this paper
• Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.

  2017cited by this paper
• Bronchodilator Delivery in Acute Airflow Obstruction

  2017cited by this paper
• Increasing implementation and delivery of pulmonary rehabilitation: key messages from the new ATS/ERS policy statement

  2016cited by this paper
• Development of a simple screening tool for opportunistic COPD case finding in primary care in Latin America: The PUMA study

  2016cited by this paper
• Effect of Endobronchial Coils vs Usual Care on Exercise Tolerance in Patients With Severe Emphysema: The RENEW Randomized Clinical Trial.

  2016cited by this paper
• E-cigarettes and smoking cessation - Authors' reply.

  2016cited by this paper
• Indacaterol-Glycopyrronium versus Salmeterol-Fluticasone for COPD.

  2016cited by this paper
• The Prevalence of Metabolic Syndrome In Chronic Obstructive Pulmonary Disease: A Systematic Review

  2016cited by this paper
• Association between electronic cigarette use and changes in quit attempts, success of quit attempts, use of smoking cessation pharmacotherapy, and use of stop smoking services in England: time series analysis of population trends

  2016cited by this paper
• Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised controlled trial.

  2016cited by this paper
• Cardiac dysfunction during exacerbations of chronic obstructive pulmonary disease.

  2016cited by this paper
• Phenotype of Spirometric Impairment in an Aging Population.

  2016cited by this paper
• Smoking cessation for people with chronic obstructive pulmonary disease.

  2016cited by this paper
• Electronic Cigarettes for Smoking Cessation: A Systematic Review.

  2016cited by this paper
• Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function.

  2016cited by this paper
• Effect of Roflumilast and Inhaled Corticosteroid/Long-Acting β2-Agonist on Chronic Obstructive Pulmonary Disease Exacerbations (RE(2)SPOND). A Randomized Clinical Trial.

  2016cited by this paper
• Beta-blockers in COPD: time for reappraisal

  2016cited by this paper
• Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial.

  2016cited by this paper
• Association of Psychological Disorders With 30-Day Readmission Rates in Patients With COPD.

  2016cited by this paper
• Oral Low-dose Theophylline on Top of Inhaled Fluticasone-Salmeterol Does Not Reduce Exacerbations in Patients With Severe COPD: A Pilot Clinical Trial.

  2016cited by this paper
• Lung volume reduction surgery for diffuse emphysema.

  2016cited by this paper
• Pulmonary Rehabilitation Exercise Prescription in Chronic Obstructive Pulmonary Disease: Review of Selected Guidelines: AN OFFICIAL STATEMENT FROM THE AMERICAN ASSOCIATION OF CARDIOVASCULAR AND PULMONARY REHABILITATION.

  2016cited by this paper
• Lung Volume Reduction Coil Treatment vs Usual Care in Patients With Severe Emphysema: The REVOLENS Randomized Clinical Trial.

  2016cited by this paper
• A Randomized Trial of Long-Term Oxygen for COPD with Moderate Desaturation.

  2016cited by this paper
• E-cigarettes and smoking cessation in real-world and clinical settings: a systematic review and meta-analysis.

  2016cited by this paper
• Combined pharmacotherapy and behavioural interventions for smoking cessation.

  2016cited by this paper
• Influence of N-acetylcysteine on chronic bronchitis or COPD exacerbations: a meta-analysis

  2015cited by this paper
• Retrospective Assessment of Home Ventilation to Reduce Rehospitalization in Chronic Obstructive Pulmonary Disease

  2015cited by this paper
• Erratum: reduced bone density and vertebral fractures in smokers. men and COPD patients at increased risk.

  2015cited by this paper
• Tiotropium + olodaterol shows clinically meaningful improvements in quality of life.

  2015cited by this paper
• Gastro‐esophageal reflux disease and exacerbations in chronic obstructive pulmonary disease

  2015cited by this paper
• Glycopyrronium once-daily significantly improves lung function and health status when combined with salmeterol/fluticasone in patients with COPD: the GLISTEN study—a randomised controlled trial

  2015cited by this paper
• Systematic review, meta-analysis and economic modelling of molecular diagnostic tests for antibiotic resistance in tuberculosis.

  2015cited by this paper
• A consensus document for the selection of lung transplant candidates: 2014--an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation.

  2015cited by this paper
• Lung function decline rates according to GOLD group in patients with chronic obstructive pulmonary disease

  2015cited by this paper
• Role of daytime hypoxemia in the pathogenesis of right heart failure in the obstructive sleep apnea syndrome.

  2015cited by this paper
• The Effectiveness of Anti-leukotriene Agents in Patients with COPD: A Systemic Review and Meta-analysis

  2015cited by this paper
• Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease.

  2015cited by this paper
• Phenotype of normal spirometry in an aging population.

  2015cited by this paper
• Effect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trial.

  2015cited by this paper
• Tuberculosis and chronic respiratory disease: a systematic review.

  2015cited by this paper
• Occupational exposures are associated with worse morbidity in patients with chronic obstructive pulmonary disease.

  2015cited by this paper
• Pneumonia risk with inhaled fluticasone furoate and vilanterol compared with vilanterol alone in patients with COPD.

  2015cited by this paper
• Long-acting beta2-agonist in addition to tiotropium versus either tiotropium or long-acting beta2-agonist alone for chronic obstructive pulmonary disease.

  2015cited by this paper
• A randomised trial of lung sealant versus medical therapy for advanced emphysema

  2015cited by this paper
• FLIGHT1 and FLIGHT2: Efficacy and Safety of QVA149 (Indacaterol/Glycopyrrolate) versus Its Monocomponents and Placebo in Patients with Chronic Obstructive Pulmonary Disease.

  2015cited by this paper
• Surgical Approaches to Treating Emphysema: Lung Volume Reduction Surgery, Bullectomy, and Lung Transplantation

  2015cited by this paper
• Risk of death and readmission of hospital-admitted COPD exacerbations: European COPD Audit

  2015cited by this paper
• Reply: FEV1 can be associated with reduced values after vigorous exercise in healthy adolescents.

  2015cited by this paper
• Relapse in FEV1 Decline After Steroid Withdrawal in COPD.

  2015cited by this paper
• Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials.

  2015cited by this paper
• Effect of tele health care on exacerbations and hospital admissions in patients with chronic obstructive pulmonary disease: a randomized clinical trial

  2015cited by this paper
• Clinical and Radiologic Disease in Smokers With Normal Spirometry.

  2015cited by this paper
• E-cigarettes: an evidence update. A report commissioned by Public Health England.

  2015cited by this paper
• Supported self-management for patients with moderate to severe chronic obstructive pulmonary disease (COPD): an evidence synthesis and economic analysis.

  2015cited by this paper
• Blood Eosinophils: A Biomarker of Response to Extrafine Beclomethasone/Formoterol in Chronic Obstructive Pulmonary Disease.

  2015cited by this paper
• Lung cancer in patients with chronic obstructive pulmonary disease. Development and validation of the COPD Lung Cancer Screening Score.

  2015cited by this paper
• Reduced Bone Density and Vertebral Fractures in Smokers. Men and COPD Patients at Increased Risk.

  2015cited by this paper
• Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2007 and 2011 staging systems: a pooled analysis of individual patient data.

  2015cited by this paper
• The Association Between Hospital Readmission and Pulmonologist Follow-up Visits in Patients With COPD.

  2015cited by this paper
• Long-acting muscarinic antagonists

  2015cited by this paper
• Aclidinium bromide and formoterol fumarate as a fixed-dose combination in COPD: pooled analysis of symptoms and exacerbations from two six-month, multicentre, randomised studies (ACLIFORM and AUGMENT)

  2015cited by this paper
• Predischarge bundle for patients with acute exacerbations of COPD to reduce readmissions and ED visits: a randomized controlled trial.

  2015cited by this paper
• Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial.

  2015cited by this paper
• Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography.

  2015cited by this paper
• Efficacy and Safety of Umeclidinium Added to Fluticasone Propionate/Salmeterol in Patients with COPD: Results of Two Randomized, Double-Blind Studies

  2015cited by this paper
• Endobronchial Valves for Emphysema without Interlobar Collateral Ventilation.

  2015cited by this paper
• Clinical Relevance of Fixed Ratio vs Lower Limit of Normal of FEV1/FVC in COPD: Patient-Reported Outcomes From the CanCOLD Cohort

  2015cited by this paper
• A randomised controlled trial of the clinical effectiveness and cost-effectiveness of the levonorgestrel-releasing intrauterine system in primary care against standard treatment for menorrhagia: the ECLIPSE trial.

  2015cited by this paper
• Nocturnal noninvasive positive pressure ventilation in stable COPD: a systematic review and individual patient data meta-analysis.

  2014cited by this paper
• Use of inhaled corticosteroids in patients with COPD and the risk of TB and influenza: A systematic review and meta-analysis of randomized controlled trials. a systematic review and meta-analysis of randomized controlled trials.

  2014cited by this paper
• Counterpoint: Is an increase in FEV₁ and/or FVC ≥ 12% of control and ≥ 200 mL the best way to assess positive bronchodilator response? No.

  2014cited by this paper
• Statin use and exacerbations in individuals with chronic obstructive pulmonary disease

  2014cited by this paper
• Impact of self-reported Gastroesophageal reflux disease in subjects from COPDGene cohort

  2014cited by this paper
• Chinese water-pipe smoking and the risk of COPD.

  2014cited by this paper
• Electronic cigarettes for smoking cessation and reduction.

  2014cited by this paper
• Does the 2013 GOLD classification improve the ability to predict lung function decline, exacerbations and mortality: a post-hoc analysis of the 4-year UPLIFT trial

  2014cited by this paper
• Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): a randomised, double-blind, placebo-controlled trial.

  2014cited by this paper
• HIV-associated obstructive lung diseases: insights and implications for the clinician.

  2014cited by this paper
• Tiotropium versus placebo for chronic obstructive pulmonary disease.

  2014cited by this paper
• Can early introduction of specialized palliative care limit intensive care, emergency and hospital admissions in patients with severe and very severe COPD? a randomized study

  2014cited by this paper
• Nocturnal non-invasive ventilation in COPD patients with prolonged hypercapnia after ventilatory support for acute respiratory failure: a randomised, controlled, parallel-group study

  2014cited by this paper
• A critical review of the effectiveness of ‘teach-back’ technique in teaching COPD patients self-management using respiratory inhalers

  2014cited by this paper
• Non-invasive positive pressure ventilation for the treatment of severe stable chronic obstructive pulmonary disease: a prospective, multicentre, randomised, controlled clinical trial.

  2014cited by this paper
• Use of Inhaled Corticosteroids in Patients With COPD and the Risk of TB and Influenza: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

  2014cited by this paper
• Withdrawal of inhaled glucocorticoids and exacerbations of COPD.

  2014cited by this paper
• “The unpredictable death”—The last year of life for patients with advanced COPD: Relatives' stories

  2014cited by this paper
• Tadalafil in patients with chronic obstructive pulmonary disease: a randomised, double-blind, parallel-group, placebo-controlled trial.

  2014cited by this paper
• Lung Function and Incidence of Chronic Obstructive Pulmonary Disease after Improved Cooking Fuels and Kitchen Ventilation: A 9-Year Prospective Cohort Study

  2014cited by this paper
• Targeting occult heart failure in intensive care unit patients with acute chronic obstructive pulmonary disease exacerbation: effect on outcome and quality of life.

  2014cited by this paper
• Home non-invasive ventilation use following acute hypercapnic respiratory failure in COPD.

  2014cited by this paper
• Short- and medium-term prognosis in patients hospitalized for COPD exacerbation: the CODEX index.

  2014cited by this paper
• Observational study to characterise 24-hour COPD symptoms and their relationship with patient-reported outcomes: results from the ASSESS study

  2014cited by this paper
• Self management for patients with chronic obstructive pulmonary disease.

  2014cited by this paper

• New approaches to uncover COPD pathobiology and develop therapies.

  2026cites this paper
• Respiratory syncytial virus is associated with a higher disease burden than influenza and SARS-CoV-2 in adults with chronic lung disease: a multi-center cohort study

  2026cites this paper
• Global Trends in COPD Self-Management Research: A Dual-Perspective Bibliometric Analysis (January 2005–July 2025)

  2026cites this paper
• Targeting the Keap1-Nrf2 Axis in COPD: Comparative analysis of electrophilic and peptide-based Nrf2 activators in airway and immune cells.

  2026cites this paper
• Perioperative respiratory rehabilitation: evolving concepts and clinical applications

  2026cites this paper
• Dynamic changes of immune cells and therapeutic responses in experimental models of COPD

  2026cites this paper
• Initial Treatment of COPD with LABA-LAMA Versus LAMA: Real-World Comparative Effectiveness and Safety.

  2026cites this paper
• Practical Geometric and Quantum Kernel Methods for Predicting Skeletal Muscle Outcomes in chronic obstructive pulmonary disease

  2026cites this paper
• Regenerative Therapeutics for Chronic Obstructive Pulmonary Disease

  2026cites this paper
• Prevalence and Risk Factors of Chronic Obstructive Pulmonary Disease among Adult Smokers

  2026cites this paper
• Lung health in the Terai region of Nepal

  2026cites this paper
• The effects of traditional Chinese mind-body exercise on pulmonary rehabilitation in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.

  2026cites this paper
• Designing a Digital Twin for the Management of Noncommunicable Diseases: Protocol for a Pilot Study and Methodology Validation

  2026cites this paper
• Prediction Score of Pseudomonas Aeruginosa Isolation in Acute Exacerbations of Chronic Obstructive Pulmonary Disease.

  2026cites this paper
• Exploring the Novel Concept of Integrating Health Records and Environmental Data to Improve Care for Displaced Populations: A Commentary.

  2026cites this paper
• Which Training Is More Effective in Post-COVID-19 Geriatric Patients with COPD: Cycle Ergometer Interval Training or Continuous Training?

  2026cites this paper
• Exploring Causal Effects of Sarcopenia on Chronic Obstructive Pulmonary Disease and Hospitalization Risk: A Bi-Directional Mendelian Randomization Study.

  2026cites this paper
• Real-world safety profile of roflumilast: a pharmacovigilance analysis using FDA adverse event reporting system and Canada vigilance database

  2026cites this paper
• Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories, 1990–2021: results from the Global Burden of Disease Study 2021

  2026cites this paper
• Boehmeria nivea (L.) Gaud. ameliorate oxidative stress-mediated inflammatory Responses and apoptosis in LPS/CSC-induced chronic obstructive pulmonary disease mouse model

  2026cites this paper
• All-Cause and Cause-Specific Mortality in Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis

  2025cites this paper
• Phytochemical Screening of Neem Plant (Azadirachta indica) against Androgen Receptor Protein for the Treatment of Prostate Cancer through Pharmacoinformatics and Molecular Dynamics Simulation

  2025cites this paper
• Integrated multi-omics profiling for risk stratification in Asians with COPD

  2025cites this paper
• Effectiveness of village doctors led cognitive behavioral therapy for COPD patients in a randomized controlled trial

  2025cites this paper
• IgE Guided Use of ICS in Patients with Stable COPD: A Real-World Observational Study

  2025influential citation
• Initial treatment of COPD with LABA-ICS or LABA-LAMA: real-world comparative effectiveness

  2025cites this paper
• Reliability and Validity of Upper Limb Muscle Strength Measurements by Handheld Dynamometer in Patients With Chronic Obstructive Pulmonary Disease

  2025cites this paper
• Impact of comorbid depression on quality of life and disease progression in chronic obstructive pulmonary disease: a correlational analysis

  2025cites this paper
• Dose-response relationship of physical activity and sedentary time with mortality in people with chronic obstructive pulmonary disease: an analysis of UK biobank accelerometer cohort

  2025cites this paper
• Association of Obesity with Symptoms and Quality of Life in COPD: Results from COSYCONET

  2025influential citation
• Efficacy and health economics of Bufei Yishen granules in patients with frequent exacerbator phenotype in the stable phase of chronic obstructive pulmonary disease: study protocol for a multicenter, randomized, double-blind, placebo-controlled trial

  2025cites this paper
• Airway hyperresponsiveness to mannitol in relation to inspiratory and expiratory resistance in subjects with asthma, COPD, and healthy smokers

  2025cites this paper
• Rectifying COPD management: a critical analysis of the Global Initiative for Chronic Obstructive Lung Disease strategy

  2025cites this paper
• Risk stratification system and visualized dynamic nomogram constructed for predicting postoperative pneumonia in geriatric patients with hip fracture

  2025cites this paper
• Healthcare professionals’ representation toward optimal palliative care provision for COPD patients: a cross-sectional survey

  2025cites this paper
• Deep Learning of Suboptimal Spirometry to Predict Respiratory Outcomes and Mortality

  2025cites this paper
• Causal relationship between multiple sclerosis and asthma and chronic obstructive pulmonary disease based on genome-wide association study data

  2025cites this paper
• From Breathlessness to Better Living: Transforming COPD Care with Home-based Pulmonary Rehabilitation

  2025cites this paper
• Diagnostic value of CRP, PCT, NC, and NLR in peripheral blood for bacterial infections in non-small cell lung cancer patients after chemotherapy

  2025cites this paper
• Comparative Efficacy and Safety of Short- Versus Standard-course Fluoroquinolone Treatment in Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Meta-analysis of Double-blind Studies.

  2025cites this paper
• Pharmacologic Treatment of COPD: Disparities Between Evidence and Recommendations in GOLD 2023/4

  2025cites this paper
• Immunohistochemical Analysis of Mastocyte Inflammation: A Comparative Study of COPD Associated with Tobacco Smoking and Wood Smoke Exposure

  2025cites this paper
• Efficacy and safety of dietary polyphenol supplements for COPD: a systematic review and meta-analysis

  2025cites this paper
• Evaluation of the relationship between sleep quality, physical activity level, and functional capacity in chronic obstructive pulmonary disease

  2025cites this paper
• Unified Acoustic Representations for Screening Neurological and Respiratory Pathologies from Voice

  2025cites this paper
• Ambient air pollution exposure, mediating biomarkers and risk of COPD: a cohort study and meta-analysis

  2025cites this paper
• Effect of different forms of upper limb muscle training on dyspnea in chronic obstructive pulmonary disease: a randomised controlled trial.

  2025cites this paper
• Study protocol for a multicentre, randomised controlled trial in China to evaluate the efficacy and safety of precise subsegmental bronchoscopic thermal vapour ablation treatment in severe emphysema

  2025cites this paper
• A systematic review of pulmonary rehabilitation nursing interventions for patients with chronic obstructive pulmonary disease

  2025cites this paper
• Clinical Effectiveness of High-Flow Nasal Cannula Versus Non-invasive Ventilation in Acute COPD Exacerbations: A GRADE-Assessed Systematic Review and Meta-analysis with Trial Sequential Analysis of Randomized Controlled Trials

  2025cites this paper
• Novel Maintenance Therapies for Chronic Obstructive Pulmonary Disorder

  2025cites this paper
• Transforming acute exacerbations of chronic obstructive pulmonary disease (AECOPD) risk assessment: A multi‐algorithm machine learning approach for precise clinical phenotyping

  2025cites this paper
• Fezakinumab Alleviates Cigarette Smoke–Induced COPD by Suppressing the JAK1/STAT3 Pathway in Mice

  2025cites this paper
• Adipose–Muscle Crosstalk in COPD Cachexia: Early Adipose Atrophy Drives Subsequent Muscle Wasting

  2025cites this paper
• Metabolic syndrome, small airway dysfunction and the mediating role of inflammation

  2025cites this paper
• Drago®: an innovative mobile application to improve adherence and complience of house dust mite allergen immunotherapy

  2025cites this paper
• Sputum SLC40A1 as a Novel Biomarker is Increased in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

  2025cites this paper
• Perspectives on Palliative Care Approaches in People with Advanced COPD: A Qualitative Study of Patients Attending a Breathe Easy Clinic and Day Hospice

  2025cites this paper
• Spiraea prunifolia var. simpliciflora leaves ameliorate inflammatory responses and oxidative stress in PPE/LPS-induced chronic obstructive pulmonary disease mouse model

  2025cites this paper
• Soyasaponin I alleviates inflammation and oxidative stress in chronic obstructive pulmonary disease through inhibiting the mitogen-activated protein kinase (MAPK) signaling pathway

  2025cites this paper
• Identification and Experimental Validation of Biomarkers Related to MiR-125a-5p in Chronic Obstructive Pulmonary Disease

  2025cites this paper
• Magnesium sulfate in oxidative stress-associated pathologies: clinical, cellular, and molecular perspectives

  2025cites this paper
• Efficacy and safety of medroxyprogesterone acetate on noninvasive ventilation -treated exacerbated COPD patients: a double-blind randomized clinical trial

  2025cites this paper
• Mortality From Infectious Pneumonia Associated With the Severity of Airflow Limitation in Pneumoconiosis

  2025cites this paper
• Geriatric-Specific Considerations in the Care of Older Adults with Pulmonary/Respiratory Diseases.

  2025cites this paper
• Adherence to Pharmacological Management Guidelines for Stable Chronic Obstructive Lung Disease

  2025cites this paper
• Chronic obstructive pulmonary disease burden attributable to tobacco and the trend change from 1990 to 2021 in China

  2025influential citation
• Development and qualification of an LC-MS/MS method for quantification of MUC5AC and MUC5B mucins in spontaneous sputum

  2025cites this paper
• The Association of Toll-like Receptor-9 Gene Single-Nucleotide Polymorphism and AK155(IL-26) Serum Levels with Chronic Obstructive Pulmonary Disease Exacerbation Risk: A Case-Controlled Study with Bioinformatics Analysis

  2025cites this paper
• Assessment of the right ventricular strain, left ventricular strain and left atrial strain using speckle tracking echocardiography in patients with chronic obstructive pulmonary disease

  2025cites this paper
• Factors Influencing Mechanical Ventilation and Inpatient Palliative Care Utilization in Patients With Chronic Obstructive Pulmonary Disease

  2025cites this paper
• Nomogram to predict progression from preserved ratio impaired spirometry to chronic obstructive pulmonary disease

  2025cites this paper
• Awareness and barriers of adherence to chronic obstructive pulmonary disease guidelines among respiratory therapists

  2025cites this paper
• Prediction of potential active ingredients and mechanism of Forsythia suspense leaf green tea extract in treating COPD mice based on UPLC‐MS and network pharmacology

  2025cites this paper
• Outcomes in Patients with Long COVID-19 One Year After their Discharge from Intensive Care Units

  2025cites this paper
• Biomarkers (NLR, PLR, SII) for Frequent COPD Exacerbations: Diagnostic and Clinical Management Implications in a Retrospective Study

  2025cites this paper
• Relationship among depressive symptoms, dyspnea-related fear and sarcopenia in patients with chronic obstructive pulmonary disease: The mediating effect of physical activity

  2025cites this paper
• The predictive role of identifying frailty in assessing the need for palliative care in the elderly: the application of machine learning algorithm

  2025cites this paper
• Guideline-concordant inhaled medication use in COPD: a systematic review of definitions used in administrative health data

  2025cites this paper
• AN OVERVIEW OF COPD: ITS ADVANCED THERAPEUTIC MANAGEMENT AND CHALLENGES FOR DRUG RELEASE AT THE TARGETED SITE

  2025cites this paper
• High flow nasal therapy versus noninvasive ventilation for AECOPD with acute hypercapnic respiratory failure: a meta-analysis of randomized controlled trials

  2025cites this paper
• Role of Heart Rate Recovery in Chronic Heart Failure: Results From the MyoVasc Study

  2025cites this paper
• Shared loci but distinct variants underlie genetic architecture of allergic diseases

  2025cites this paper
• Inflammatory lung diseases: a clinical and scientific review of the latest advances and challenges

  2025influential citation
• Alterations of retinal microvascular density in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis.

  2025cites this paper
• Genetic Factors Explain Half of the Individual Susceptibility to Chronic Bronchitis, Airflow Obstruction and COPD Regardless of the Spirometric Definition: A Nationwide Twin Study

  2025cites this paper
• A phenome-wide association study of genetically determined nicotine metabolism reveals novel links with health-related outcomes

  2025cites this paper
• Acupuncture for Chronic Obstructive Pulmonary Disease: A 38-Year Bibliometric Landscape of Global Research Trends and Knowledge Evolution (1986–2024)

  2025cites this paper
• Mosaic Loss of Y chromosome associates with lung function, emphysema and epigenetic aging

  2025influential citation
• Ambient air pollution exposures and alterations in health biomarkers: evidence from a prospective observational study

  2025influential citation
• Reduced lung function among non-smoking workers in the paper industry in Ethiopia: a comparative cross-sectional study

  2025influential citation
• Inflammatory and Mucociliary Dysfunction-Based Endotypes Across the Spectrum of Chronic Airway Diseases

  2025influential citation
• Predictors of COPD exacerbations differ between grades of airflow limitation

  2025influential citation
• The Role of Interleukin-13 in Chronic Airway Diseases: A Cross-Sectional Study in COPD and Asthma–COPD Overlap

  2025cites this paper
• CD131 antagonism blocks inflammation, emphysema and fibrosis in an asthma‐COPD overlap mouse model originating in early life

  2025cites this paper
• Chinese Herbal Medicine in Hypoxic Pulmonary Hypertension Treatment: Mechanisms, Progress, and Future Directions

  2025cites this paper
• Toward precision medicine in COPD: phenotypes, endotypes, biomarkers, and treatable traits

  2025cites this paper
• Quantitative Computed Tomography Biomarkers of Emphysema Severity in Chronic Obstructive Pulmonary Disease: Insights from Muscle Mass, Fat Volume, and Vascular Dimensions

  2025cites this paper
• Post-tuberculosis morbidities and their associated mortality: moving from challenges to solutions

  2025cites this paper
• Early screening of lung function by electrical impedance tomography in people with normal spirometry reveals unrecognized pathological features

  2025cites this paper